logoTry Persana

Sixfold Bioscience - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Sixfold Bioscience including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Sixfold Bioscience company logo

AI-enabled biotechnology creating solutions to RNA delivery problems.

Sixfold Bioscience is a biotechnology company focusing on RNA delivery solutions, leveraging AI to tackle delivery challenges in medical applications.

HeadquartersLondon, United Kingdom
Team size11-50
FoundedNA

What is Sixfold Bioscience? - Company Overview & Details

Sixfold Bioscience is Sixfold Bioscience is a biotechnology company focusing on RNA delivery solutions, leveraging AI to tackle delivery challenges in medical applications., the company is headquartered in London, United Kingdom.

Who Founded Sixfold Bioscience?

Sixfold Bioscience was founded by Anna Perdrix Rosell.

Who are the Key Executives at Sixfold Bioscience? - Leadership Team

Sixfold Bioscience is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Sixfold Bioscience

Anna Perdrix RosellCEO

Chief Technology Officer (CTO) of Sixfold Bioscience

CTO

About Anna Perdrix Rosell - CEO of Sixfold Bioscience

Anna Perdrix Rosell serves as the Chief Executive Officer of Sixfold Bioscience, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Sixfold Bioscience Company Details & Key Information

Where is Sixfold Bioscience located?

Sixfold Bioscience is headquartered in London, United Kingdom.

How many employees does Sixfold Bioscience have?

Sixfold Bioscience has 11-50 employees.

Sixfold Bioscience Official Website

How much funding has Sixfold Bioscience raised?

Sixfold Bioscience has raised $10.5 million across 1 funding rounds. The most recent funding was completed on 2021-12-02.

Funding Overview

Sixfold Bioscience raised $10.5 million in seed funding to support its RNA therapeutic delivery platform.

$10.5 million
Total Funding Raised
1
Funding Rounds
2021-12-02
Latest Round

Sixfold Bioscience Funding History

Seed
2021-12-02
$10.5 million

Who are the key investors in Sixfold Bioscience?

Sixfold Bioscience is backed by 1 key investors including Y Combinator. These investors focus on Biotechnology, Healthcare, AI sectors.

Sixfold Bioscience Investor Overview

1
Key Investors
3
Focus Areas
1
Notable Investments

Complete List of Sixfold Bioscience Investors

Y Combinator

A prominent startup accelerator and investment firm.

Investment Focus
Biotechnology
Healthcare
AI
Notable Portfolio Companies
None specified

What sectors do Sixfold Bioscience investors focus on?

The investors backing Sixfold Bioscience primarily focus on Biotechnology, Healthcare, AI sectors.

Biotechnology
Healthcare
AI

Featured Investor: Y Combinator

Y Combinator

A prominent startup accelerator and investment firm.

Notable Investments: None specified

What are Sixfold Bioscience's future plans?

Sixfold Bioscience To expand its RNA delivery systems targeting various therapeutic indications.

Sixfold Bioscience Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Sixfold Bioscience face?

Sixfold Bioscience has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Sixfold Bioscience

1

Regulatory approvals

2

Competition in biotechnology sector

What opportunities does Sixfold Bioscience have?

Sixfold Bioscience has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Sixfold Bioscience

1

Expanding their therapeutic applications

2

Growing interest in RNA therapies

Sixfold Bioscience Strategic Position Summary

Key Focus Areas

Sixfold Bioscience is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Sixfold Bioscience?

Sixfold Bioscience has 2 recent news updates covering key business developments and market activities.

Sixfold Bioscience News Overview

2
Recent Articles
Active
Media Coverage
2024-01-03
Latest Update

What is Sixfold Bioscience in the news for?

Sixfold Bioscience is currently featured in news for Sixfold Bioscience Ltd hired Søren Ottosen as Vice President of Research and other significant business developments.

Recent News Articles About Sixfold Bioscience

Article 1
2024-01-03

Sixfold Bioscience Ltd hired Søren Ottosen as Vice President of Research

Søren Ottosen, Ph.D. was appointed as Vice President of Research as part of the company's leadership expansion.

sixfold.bio
Read News
Article 2
2023-12-27

Sixfold Bioscience Ltd hired Neil Lawrence as Scientific Advisory Board

Neil Lawrence joined the Scientific Advisory Board to leverage advances in machine learning for RNA delivery.

sixfold.bio
Read News

Sixfold Bioscience FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Sixfold Bioscience including information about founders, CEO, funding history, investors, headquarters location, and company details. 17 frequently asked questions covering key information about the company.

Sixfold Bioscience Questions & Answers - Company Information

Q1

What is Sixfold Bioscience?

Sixfold Bioscience is a biotechnology company focusing on RNA delivery solutions, leveraging AI to tackle delivery challenges in medical applications.

Q2

Who founded Sixfold Bioscience?

Sixfold Bioscience was founded by Anna Perdrix Rosell.

Q3

Who is the CEO of Sixfold Bioscience?

The CEO of Sixfold Bioscience is Anna Perdrix Rosell. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Sixfold Bioscience raised?

Sixfold Bioscience has raised a total of $$10.5 million across 1 funding rounds. The most recent funding was completed on 2021-12-02.

Q5

Who are the investors in Sixfold Bioscience?

Sixfold Bioscience's key investors include Y Combinator.

Q6

Where is Sixfold Bioscience headquartered?

Sixfold Bioscience is headquartered in London, United Kingdom.

Q7

How many employees does Sixfold Bioscience have?

Sixfold Bioscience has 11-50 employees.

Q8

What is Sixfold Bioscience's official website?

You can visit Sixfold Bioscience's official website at https://www.sixfold.bio.

Q9

What was Sixfold Bioscience's latest funding round?

Sixfold Bioscience's latest funding round was a Seed round of $$10.5 million completed on 2021-12-02.

Q10

Who is founder?

Anna Perdrix Rosell

Q11

What does the company do?

Sixfold Bioscience develops RNA delivery systems using AI to overcome delivery challenges.

Q12

How much funding?

$10.5 million

Q13

Latest funding date?

2021-12-02

Q14

Who are the investors?

Y Combinator

Q15

What are the challenges?

Regulatory approvals Competition in biotechnology sector

Q16

What are the opportunities?

Expanding their therapeutic applications Growing interest in RNA therapies

Q17

Latest news?

Søren Ottosen, Ph.D. was appointed as Vice President of Research as part of the company's leadership expansion. Neil Lawrence joined the Scientific Advisory Board to leverage advances in machine learning for RNA delivery.

More Information About Sixfold Bioscience

For additional details about Sixfold Bioscience, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.